Cargando…

Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials

BACKGROUND: Antipsychotic drugs and especially the newer compounds are known to cause metabolic side effects. However, a comprehensive comparison of the different substances regarding their propensity to cause metabolic side effects in medium- to long-term treatment of schizophrenia is lacking. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schneider-Thoma, Johannes, Kapfhammer, Angelika, Wang, Dongfang, Bighelli, Irene, Siafis, Spyridon, Wu, Hui, Hansen, Wulf-Peter, Davis, John M., Salanti, Georgia, Leucht, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330017/ https://www.ncbi.nlm.nih.gov/pubmed/34340713 http://dx.doi.org/10.1186/s13643-021-01760-z

Ejemplares similares

T200. METABOLIC SIDE EFFECTS OF ANTIPSYCHOTIC DRUGS – PROTOCOL OF A SYSTEMATIC REVIEW AND NETWORK- METAANALYSIS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2020)

Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials
por: Siafis, Spyridon, et al.
Publicado: (2023)

Antipsychotic drugs and their effects on cognitive function: protocol for a systematic review, pairwise, and network meta-analysis
por: Feber, Lena, et al.
Publicado: (2023)

M201. MODERATORS OF WEIGHT GAIN IN RANDOMIZED CONTROLLED TRIALS OF SCHIZOPHRENIA – A META-REGRESSION ANALYSIS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2020)

Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis
por: Siafis, Spyridon, et al.
Publicado: (2023)

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022)

Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
por: Rodolico, Alessandro, et al.
Publicado: (2022)

Estimating and visualising the trade-off between benefits and harms on multiple clinical outcomes in network meta-analysis
por: Chiocchia, Virginia, et al.
Publicado: (2023)

Psychosocial treatments for relapse prevention in schizophrenia: study protocol for a systematic review and network meta-analysis of randomised evidence
por: Bighelli, Irene, et al.
Publicado: (2020)

S235. MAINTENANCE TREATMENT WITH ANTIPSYCHOTIC DRUGS IN SCHIZOPHRENIA – SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2018)

Evidence-based Shared-Decision-Making Assistant (SDM-assistant) for choosing antipsychotics: protocol of a cluster-randomized trial in hospitalized patients with schizophrenia
por: Siafis, Spyridon, et al.
Publicado: (2022)

Effects of antipsychotics on heart rate in treatment of schizophrenia: a systematic review and meta-analysis
por: Huhn, Maximilian, et al.
Publicado: (2022)

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
por: Huhn, Maximilian, et al.
Publicado: (2019)

Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trials
por: Bighelli, Irene, et al.
Publicado: (2018)

Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders
por: Rodolico, Alessandro, et al.
Publicado: (2022)

Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects
por: Siafis, Spyridon, et al.
Publicado: (2018)

F214. PSYCHOLOGICAL INTERVENTIONS FOR POSITIVE SYMPTOMS IN SCHIZOPHRENIA: A NETWORK META-ANALYSIS
por: Bighelli, Irene, et al.
Publicado: (2018)

How well do elderly patients with major depressive disorder respond to antidepressants: a systematic review and single-group meta-analysis
por: Gutsmiedl, Katharina, et al.
Publicado: (2020)

T6. SECOND GENERATION ANTIPSYCHOTIC DRUGS AND MORTALITY: A META-ANALYSIS OF PLACEBO-CONTROLLED RANDOMISED CONTROLLED TRIALS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2018)

S204. REDUCTION OF ANTIPSYCHOTIC DOSES AND POLYPHARMACY: TWO COCHRANE REVIEWS
por: Leucht, Stefan, et al.
Publicado: (2020)

Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
por: Leucht, Stefan, et al.
Publicado: (2022)

The Added Value of Liquid Antipsychotics: The Case of Quetiapine
por: Papazisis, Georgios, et al.
Publicado: (2019)

T216. VARIATION IN SIDE EFFECTS TO ANTIPSYCHOTIC TREATMENT ACROSS SCHIZOPHRENIA SPECTRUM DISORDERS
por: Susanne Neumeier, Maria, et al.
Publicado: (2020)

Informing the development of a decision aid: Expectations and wishes from service users and psychiatrists towards a decision aid for antipsychotics in the inpatient setting
por: Müller, Katharina, et al.
Publicado: (2023)

Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review
por: Tajika, Aran, et al.
Publicado: (2023)

Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis
por: Siafis, Spyridon, et al.
Publicado: (2020)

Structured implementation of digital, systematically updated guideline recommendations for enhanced adherence in schizophrenia (SISYPHOS)—protocol of a cluster-randomized trial
por: Lorenz, Carolin, et al.
Publicado: (2022)

Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?
por: Leucht, Stefan, et al.
Publicado: (2021)

Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis
por: Bighelli, Irene, et al.
Publicado: (2018)

Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
por: Siafis, Spyridon, et al.
Publicado: (2022)

O7.3. DOSE-RESPONSE META-ANALYSIS TO IDENTIFY THE OPTIMUM AND EQUIVALENT DOSES OF ANTIPSYCHOTIC DRUGS FOR SCHIZOPHRENIA
por: Leucht, Stefan, et al.
Publicado: (2018)

Effects of psychological treatments on functioning in people with Schizophrenia: a systematic review and meta-analysis of randomized controlled trials
por: Bighelli, Irene, et al.
Publicado: (2022)

Commentary on strategies for switching antipsychotics
por: Davis, John M, et al.
Publicado: (2008)

Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial
por: Huhn, Maximilian, et al.
Publicado: (2020)

Assessement of Antipsychotic Side-Effects Monitoring in Learning Disability Patients in a Medium Secure Hospital
por: Surendran, Indu, et al.
Publicado: (2023)

Crossroads of methodological choices in research synthesis: insights from two network meta-analyses on preventing relapse in schizophrenia
por: Ostuzzi, Giovanni, et al.
Publicado: (2023)

Relapse Prevention in Schizophrenia: A Systematic Review and Meta-Analysis of Second-Generation Antipsychotics versus First-Generation Antipsychotics
por: Kishimoto, Taishiro, et al.
Publicado: (2011)

Shared decision making, aggression, and coercion in inpatients with schizophrenia
por: Hamann, Johannes, et al.
Publicado: (2020)

The risk of elevated prolactin levels in pediatric patients exposed to antipsychotics for the treatment of schizophrenia and schizophrenia spectrum disorders: protocol for a systematic review and meta-analysis
por: Druyts, Eric, et al.
Publicado: (2014)

Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation
por: Loebel, Antony, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f22j2dic2mbj4b94iikm2e0rgb